Forms of benefit sharing in global health research undertaken in resource poor settings: A qualitative study of stakeholders' views in Kenya

Philosophy, Ethics, and Humanities in Medicine

Volumn 7, Issue 1, 2012, Pages

  Lairumbi, Geoffrey M ^a   Parker, Michael ^b,c   Fitzpatrick, Raymond ^b   English, Michael C ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DEVELOPING COUNTRY; HEALTH; HUMAN; INTERVIEW; KENYA; MEDICAL RESEARCH; SOCIAL PSYCHOLOGY;

BIOMEDICAL RESEARCH; DEVELOPING COUNTRIES; HUMANS; INTERVIEWS AS TOPIC; KENYA; SOCIAL VALUES; WORLD HEALTH;

EID: 84855786460     PISSN: None     EISSN: 17475341     Source Type: Journal    
DOI: 10.1186/1747-5341-7-7     Document Type: Article

References (59)

1. GFHR The 10/90 Report on Health Research 2003-2004. 2004, Davey S, GFHR.
2. Pogge TW. HUMAN RIGHTS AND GLOBAL HEALTH: A RESEARCH PROGRAM. Metaphilosophy 2005, 36(1-2):182-209.
3. Trouiller P, Torreele E, Olliaro P, White N, Foster S, Wirth D, Pécoul B. Drugs for neglected diseases: a failure of the market and a public health failure?. Tropical Medicine & International Health 2001, 6(11):945-951. 10.1046/j.1365-3156.2001.00803.x, 22262943.
4. Winters DJ. Expanding global research and development for neglected diseases. Bulletin of the World Health Organization 2006, 84:414-416. 10.2471/BLT.06.029868, 2627347, 16710555.
5. Benatar SR. Moral Imagination: The Missing Component in Global Health. PLoS Med 2005, 2(12):e400. 10.1371/journal.pmed.0020400, 1322290, 16363910.
6. Landes M. Can context justify an ethical double standard for clinical research in developing countries?. Globalization and Health 2005, 1(11).
7. Macklin R. After Helsinki: Unresolved Issues in International Research. Kennedy Inst Ethics 2001, 11(1):17-36.
8. Resnik DB. The Distribution of Biomedical Research Resources and International Justice. Developing World Bioethics 2004, 4(1):42-57. 10.1111/j.1471-8731.2004.00066.x, 15086373.
9. Schuklenk U, Ashcroft E. Affordable Access to Essential Medication in Developing Countries: Conflicts Between Ethical and Economic Imperatives. J Med Philos 2002, 27(2):179-195. 10.1076/jmep.27.2.179.2989, 11961696.
10. Weijer C, Anderson J. A critical Appraisal of Protections For Aboriginal Communities in Biomedical Research. journal of Jurimetrics 2002, 42:187-198.
11. CIOMS International Ethical Guidelines for Biomedical Research Involving Human Subjects. 2002, Council for International Organisation of Medical Sciences, CIOMS.
12. Macklin R. Double standards in medical research in developing countries 2004, Cambridge: Cambridge University Press.
13. WMA Declaration of Helsinki. 2002, Geneva, Switzerland: World Medical Association, WMA.
14. Bhutta Z. Ethics in international health research: a perspective from the developing world. Bull World Health Organ 2002, 80(2).
15. Grady C. The challenge of assuring continued post-trial access to beneficial treatment. Yale Journal of Health Policy, Law and Ethics 2005, 5(1):425-435.
16. Brody BA, McCullough LB, Sharp RR. Consensus and Controversy in Clinical Research Ethics. JAMA 2005, 294(11):1411-1414. 10.1001/jama.294.11.1411, 16174704.
17. Crouch R, Arras J. AZT Trials and tribulations. Hastings Center Report 1998, 28:26-34. 10.2307/3528266, 9868608.
18. Glantz L, Grodin M, Mariner W. Research in developing countries:taking 'benefit' seriously. Hastings Center Report 1998, 28:38-42.
19. Emanuel Ezekiel J, Wendler D, Killen J, Grady C. What Makes Clinical Research in Developing Countries Ethical? The Benchmarks of Ethical Research. The Journal of Infectious Diseases 2004, 189(5):930-937. 10.1086/381709, 14976611.
20. Hayden C. 'From market to market: Bioprospecting's Idioms of Inclusion'. American Ethnologist 2003, 30(3):1-13.
21. Hayden C. Taking as Giving: Bioscience, Exchange, and the politics of Benefit-sharing. Social Studies of Science 2007, 37(5).
22. Schulz-Baldes A, Vayena E, Biller-Andorno N. Sharing benefits in international health research: Research-capacity building as an example of indirect collective benefit. EMBO reports 2007, 8(1).
23. Simm K. Benefit-sharing: an inquiry regarding the meaning and limits of the concept in human genetic research. Genomics, Society and Policy 2005, 1(2):29-40.
24. Simm K. Benefit Sharing Frameworks: Justifications for and against benefit sharing in human genetic research. 2007, A Report for GenBenefit.
25. Ballantyne A. HIV international clinical research: exploitation and risk. Bioethics 2005, 19:476-491. 10.1111/j.1467-8519.2005.00459.x, 16425485.
26. Participants The Ancillary-Care Obligations of Medical Researchers Working in Developing Countries. PLoS Med 2008, 5(5):e90. 2386835, 18494553, Participants.
27. Participants, Conference on Ethical Aspects of Research in Developing Countries Fair benefits for research in developing countries. Science 2002, 298:2133-2134. 10.1126/science.1076899, 12481120, Participants, Conference on Ethical Aspects of Research in Developing Countries.
28. Participants) PitCoEAoRiDC Moral Standards for research in developing countries:from 'reasonable availability' to 'fair benefits'. Hastings Center Report 2004, 34:17-27. Participants) PitCoEAoRiDC.
29. Benatar S, Singer P. Responsibilities in international research:a new look revisited. J Med Ethics 2010, 36:194-197. 10.1136/jme.2009.032672, 20338927.
30. London A. Justice and the human development approach to international research. Hastings Center Report 2005, 35(1):24-37.
31. London A. Two dogmas of research ethics and the intergrative approach to human subjects research. Journal of Medicine and Philosophy 2007, 32:99-116. 10.1080/03605310701255727, 17454417.
32. London A, Zollman J. Research at the Auction Block: Problems for the Fair Benefits Approach to International Research. Hastings Center Report 2010, 40(4):34-45. 10.1353/hcr.0.0281, 20669781.
33. London AJ. The Moral Foundations of Equipoise and Its Role in International Research. The American Journal of Bioethics 2006, 6(4):48-51. 10.1080/15265160600755599, 16997826.
34. Ballantyne A. 'Fair Benefits' accounts of Exploitation Require a Normative Principle of Fairness: A Response to Gbadegesin and Wendler, and Emanuel et al. Bioethics 2008, 22(4):239-244. 10.1111/j.1467-8519.2007.00622.x, 18405322.
35. London AJ. Justice and the human development approach to international research. Hastings Center Report 2005, 35(1).
36. Hyder AA, Wali SA, Khan AN, Teoh NB, Kass NE, Dawson L. Ethical review of health research: a perspective from developing country researchers. Journal of Medical Ethics 2004, 30(1):68-72. 10.1136/jme.2002.001933, 1757137, 14872079.
37. Miller G, Rosenstein D. The Therapeutic Orientation to Clinical Trials. New England Journal of Medicine 2003, 348(14):1383-1386. 10.1056/NEJMsb030228, 12672867.
38. Miller G. Research Ethics and Misguided Moral Intuition. Journal of Law Medicine & Ethics 2004, 32(1):111-116. 10.1111/j.1748-720X.2004.tb00455.x, 22261758.
39. Grady C, Wagman J, Robert S, Wawer JM, Serwadda D, Kiddugavu M, Nalugoda F, Ronald H, Wendler D, Dong Q, et al. Research Benefits for Hypothetical HIV Vaccine Trials: The Views of Ugandans in the Rakai District. IRB 2008, 30(2).
40. MacQueen KM, Namey E, Chilongozi DA, Mteve SP, Milingo M, Morar N, Reid C, Ristow A, Sahay S. Community Perspectives on care options for HIV prevention trial participants. AIDS Care 2007, 19(4).
41. Stadler JJ, Delany S, Mntambo M. Women's perceptions and experiences of HIV prevention trials in Soweto, South Africa. Social Science & Medicine 2008, 66(1):189-200. 10.1016/j.socscimed.2007.08.021, 22262806.
42. Thiessen C, Robert S, Jennifer W, Kiddugavu M, Wawe M, Emanuel E, Ronald G, serwadda D, Grady C. Personal and community benefits and harms of research: views from Rakai, Uganda. AIDS 2007, 21(18):2493-2501. 10.1097/QAD.0b013e3282f029d3, 18025886.
43. Richards L. Using NVIVO in Qualitative Research (version 8) 2002, Melbourne, Australia,: QSR International.
44. Srivastava PHN. A practical Iterative Framework for Qualitative Data Analysis. International Journal of Qualitative Methods 2009, 8(1):76-84.
45. Benatar S, Fleischer E. Ethical issues in research in low-income countries. Int J Tuberc Lung Dis 2007, 11(6):617-623.
46. White MT. A Right to Benefit from International Research: A New Approach to Capacity Building in Less-Developed Countries. Accountability in Research 2007, 14(2):73-92. 10.1080/08989620701290341, 17844784.
47. Schroeder D, Lasen-Diaz C. Sharing The Benefits of Genetic Resources: From Biodiversity to Human Rights. Developing World Bioethics 2006, 6(3):135-143.
48. Weise KL, Smith ML, Maschke KJ, Copeland HL. National Practices Regarding Payment to Research Subjects for Participating in Pediatric Research. Pediatrics 2002, 110(3):577-582. 10.1542/peds.110.3.577, 12205263.
49. Dickert N, Grady C. What's the price of a research subject? Approaches to payment for research participation. N Engl J Med 1999, 341(3):198-203. 10.1056/NEJM199907153410312, 10403861.
50. Emanuel EJ. Ending Concerns About Undue Inducement. The Journal of Law, Medicine & Ethics 2004, 32(1):100-105. 10.1111/j.1748-720X.2004.tb00453.x, 22235798.
51. Macklin L. Against relativism: cultural diversity and the search for ethical universals in medicine. 1999,
52. Bentley J, Thacker P. The influence of risk and monetary payments on the research participation decision making process. J Med Ethics 2004, 30:293-298. 10.1136/jme.2002.001594, 1733848, 15173366.
53. Macklin L. The paradoxical Case of Payment as Benefits to Research Subjects. The Hastings Center Report 1989, 11(6).
54. Wertheimer A, Miller F. Payment for research participation: a coercive offer?. J Med Ethics 2008, 34:389-392. 10.1136/jme.2007.021857, 18448723.
55. Bagley SJ, Reynolds WW, Nelson RM. Is a "Wage-Payment" Model for Research Participation Appropriate for Children?. Pediatrics 2007, 119(1):46-51. 10.1542/peds.2006-1813, 17200270.
56. Grady C. Payment of clinical research subjects. The Journal of Clinical Investigation 2005, 115(7):1681-1687. 10.1172/JCI25694, 1159153, 16007244.
57. Israni AK, Halpern SD, Zink S, Sidhwani SA, Caplan A. Incentive Models to Increase Living Kidney Donation: Encouraging Without Coercing. American Journal of Transplantation 2005, 5(1):15-20. 10.1111/j.1600-6143.2004.00656.x, 15636607.
58. Hyder A, Wali S, Khan A, Teoh N, Kass N, Dawson L. Ethical review of health research: a perspective from developing country researchers. Journal of Medical Ethics 2004, 38:68-72.
59. Ijsselmuiden C, Kass NE, Sewankambo N, Lavery J. Evolving values in ethics and global research. Global Public Health 2010, 5(2).